磷酸鈣鹽 的英文怎麼說
中文拼音 [līnsuāngàiyán]
磷酸鈣鹽
英文
synthos-
Administration of calciferol to patients in excess of their daily requirements can cause hypercalcemia, hypercalciuria and hyperphosphatemia
舉例:給病人服用骨化醇超過每日需要量,可引起高鈣血,高鈣尿和高磷酸鹽血癥。Di - basic calcium phosphate anhydrous
無水二鹽基磷酸鈣Microemulsion controlling nano - structured mineralization of calcium phosphate
微乳膠調控的磷酸鈣鹽納米結構礦化材料研究When the solvent was pure 1, 4 - dioxane foams showed ladder - like structure and calcium phosphate besetted in the plla pore wall and has good combination. the size of conglomeration is only l ~ 5 m
溶劑為極性較小的純1 , 4一二氧六環時,材料具有梯狀的孔結構,鈣磷酸鹽鑲嵌在plla孔壁中,與pla結合情況較好,分散均勻,尺寸在1一5林m 。Through the analyzing the macro - structure to micro - structure, the author considers that retarding mechanism of citric acid is that citric acid and ca in the gypsum form the complexant ion, and hinder the crystallization center of dihydrate crystal bigger ; that of sodium tripolyphosphate is that it combined with ca, hinders the dissolve of hemihydrate. formation and growth of crystallization center ; that of bone glue is the glue - protection and chemical absorption action of active group, which also retards the formation and growth of crystallization center
通過宏觀到微觀的分析,筆者認為,檸檬酸的緩凝作用的原因主要在於檸檬酸與鈣形成絡合離子,影響了二水石膏晶體的晶核長大過程;多聚磷酸鈉與鈣形成某種復鹽,對于石膏晶體的溶解、成核和長大過程均有強烈的阻礙影響;骨膠則在於膠體對半水石膏的包裹和活性基團的化學吸附,使二水石膏晶體的成核和長大困難。This work provides an effective way to prepare high porosity ( 80 % ~ 93 % ) and big pore size ( 50 ~ 300 m ) cp / plla composite scaffold. pf127 as progen increased the pore size and enhanced the hydrophile ability of plla
本工作通過相分離法制備了高孔隙率( 80吩93 % ) ,孔徑在50一300娜鈣磷酸鹽和聚乳酸復合的多孔材料。With your know - how with things alcohol, mica, with titanium, lithopone or paraffin, phosphate, also polyethylene and titanium dioxide, its worth it to enquire by e - mail, in order to receive an interesting offer from the enterprise
通過電子郵件或電話咨詢方式,您可以獲悉關于供給營養、喂養、給食、營養、食物、贍養、撫養、替換材料的具體介紹,您當然也可以垂詢鈣和磷鹽酸、磷酸酯。Screen test for dcp, limestone and salt
篩選檢驗磷酸氫鈣,石粉和食鹽Phosphates and sodium nitrate are used for the sequestration of insoluble calcium or magnesium salts, while the task of removing mineral deposits from stainless steel surfaces is facilitated by the use of acid solutions, usually solutions of nitric or phosphoric acid
磷酸鈉及硝酸鈉用於隔離不能溶解的鈣鹽或鎂鹽,而從不銹鋼表面去除沉積的無機物通常使用酸溶液,一般是用含氮酸或磷酸溶液。We make superphosphate by reacting rock phosphate with sulphuric acid
我們使磷酸鹽巖同硫酸發生化學反應製造過磷酸鈣。Objective to report 16 cases of intracranial aneurysms with calcified vascular wall and study the relationship between vascular calcification and pathogenic mechanism of intracranial aneurysms. methods spiral ct scan, clinical data and serum calcium, phosphate, glucose, lipid, renal function of the 16 patients were studied in retrospect. all aneurysms were clipped, in which 8 were resected after clipping. results the location of aneurysms with aneurismal wall calcification was, on posterior communicating artery in 3, on middle cerebral artery in 2, on anterior communicating artery in 2, on basilar artery in 5 and on basilar artery in 4. all patients showed normal serum calcium, phosphate, glucose and normal renal function. serum lipid of patients had been elevated. all patients recovered with no significant neurological deficits. conclusion intracranial vascular calcification is an active and regulated process in close relation to atherosclerosis, serum calcium, phosphate, lipid, thyroid, parathyroid function and other factors. intracranial vascular calcification has close relationship with the pathogenesis and management of intracranial aneurysms
目的報告16例瘤壁有鈣化的顱內動脈瘤病例的治療,分析顱內血管鈣化與顱內動脈瘤病理發生機制的關系.方法回顧性分析16例瘤壁有鈣化的顱內動脈瘤病例的影像學、臨床資料及手術治療.結果瘤壁有鈣化的顱內動脈瘤的位置是: 3例位於后交通動脈, 2例位於大腦中動脈, 2例位於前交通動脈, 5例位於椎動脈, 4例位於基底動脈.所有患者血鈣、磷酸鹽、血糖、腎功能正常. 6例患者血脂增高. 16例患者均行動脈瘤夾閉術,其中8例術中切除動脈瘤,治療效果良好.結論動脈瘤瘤壁鈣化與其病理發生機制有關,常見于巨大或大動脈瘤,瘤壁血管鈣化是與動脈粥樣硬化、血鈣、磷酸鹽、血脂、甲狀腺、甲狀旁腺等因素有關的主動耗能,多因素調控的病理過程Various kinds of crystals were detected from urinalysis including calcium oxalate, amorphous phosphate, triple phosphate and uric acid in 83 patients ( 37. 9 % ) of the urinary calculus group and 13 patients ( 12. 6 % ) of the non - calculus group
同時,我們發現在83位( 37 . 9 % )尿路結石病患及13位( 12 . 6 % )非結石病患的尿液中存在著各類結晶體,包括草酸鈣、無定形性磷酸鹽、三重磷酸鹽及尿酸結晶體等。Acid phoshate mixer
過磷酸鈣鹽混合器Calcium phosphates ( cp ) have been studied extensively for cell cultures and have been found to possess good osteoconductive properties. cp can be dissolved in vivo and be absorbed or displaced by tissue. the degradation rate of cp varies in different crystalline phases, which enables to adjust the degradation rate of biomaterials
鈣磷酸鹽如磷酸三鈣具有骨誘導性,在體內有較大的溶解度,易發生水化作用,並通過體液的侵蝕和細胞的吞噬作用被機體部分或完全吸收而被取代,不同晶型的鈣磷酸鹽在體內的降解速率不同,可調整材料的降解速率。The markedly elevated phosphate levels, coupled with very low calcium levels, led us to conclude that the cause of death was cardiorespiratory failure as a consequence of phosphate overdose
血磷水平明顯升高和與其相符合的低鈣血癥使我們得出結論:超量的磷酸鹽引起心肺功能衰竭導致死亡。Many business partners also estimate the offer pallets of beijing chemical raw materials co. tianli paint wholesale department, like calcium, titanium dioxide and external as well as calcium
通過電子郵件或電話咨詢方式,您可以獲悉關于供給營養、喂養、給食、營養、食物、贍養、撫養、替換材料的具體介紹,您當然也可以垂詢鈣和磷鹽酸、磷酸酯。Our company mainly has the phosphoric products, for example sodium salt, calcium salt and so on
公司主要產品有:鈉鹽、鈣鹽等磷酸鹽精細產品。In this work, pluronic f127 was used as a progen and different biodegradation rate and surface property as amorphous calcuim phosphate, a - calcuim triphosphate, - calcuim triphosphate and a / p - calcuim triphosphate were selected to make three - dimensional porous composites with plla. in the phase separation of pure plla or cp / plla composite system the ppo block of pf127 can aggregate plla clew to induce phase separation. this resulted big round pores of 50 ~ 300 m and uniform ladder - like structure of 400 ~ 1000 m
具體結果如下:浙江大學碩士學位論文在單純的聚乳酸以及鈣磷酸鹽/聚乳酸復合體系的相分離過程中, pf127的ppo鏈段對plla鏈段有聚集作用,促進相分離過程,在不同溶劑中分別可得到孔徑在50一300林m的較大的圓孔和有序度為400一1000林m的梯狀孔,孔隙率為80 % ~ 93 % 。The addition of cp can enhance the mechanical ability of plla greatly and give good osteoconductive properties
用鈣磷酸鹽增強plla ,可得到大幅度提高plla的初始強度,增加plla的力學相容性和骨誘導性。A peptide hormone, produced by the thyroid gland in human beings, that lowers plasma calcium and phosphate levels without augmenting calcium accretion
降鈣素一種縮氨酸荷爾蒙,由人體內的甲狀腺產生。在不增加鈣含量的情況下,可降低血中鈣和磷酸鹽的含量分享友人